Liver cancer is one of the most common
cancers in the world and
has no effective cure, especially in later stages. The development
of a tangible protocol for early diagnosis of this disease remains
a major challenge. In the present manuscript, an aptamer-based, label-free
electrochemical biosensor for the sensitive detection of HepG2, a
hepatocellular carcinoma cell line, is described. The target cells
are captured in a sandwich architecture using TLS11a aptamer covalently
attached to a gold surface and a secondary TLS11a aptamer. The application
of TLS11a aptamer as a recognition layer resulted in a sensor with
high affinity for HepG2 cancer cells in comparison with control cancer
cells of human prostate, breast, and colon tumors. The aptasensor
delivered a wide linear dynamic range over 1 × 102 to 1 × 106 cells/mL, with a detection limit of 2
cells/mL. This protocol provides a precise method for sensitive detection
of liver cancer with significant advantages in terms of simplicity,
low cost, and stability.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.